Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs

scientific article published on 13 December 2015

Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.EJMECH.2015.12.016
P698PubMed publication ID26717201

P2093author name stringJun He
Jie Liu
Jin Zhang
Jingjing Li
Jinhui Wang
Mingrui Guo
Shouyue Zhang
Liang Ouyang
Yingnan Jiang
Xiangdong Jiang
P304page(s)495-504
P577publication date2015-12-13
P1433published inEuropean Journal of Medicinal ChemistryQ3008624
P1476titleRecent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs
P478volume108

Reverse relations

cites work (P2860)
Q38642364Acylated Iridoids and Rhamnopyranoses from Premna odorata (Lamiaceae) as Novel Mesenchymal-Epithelial Transition Factor Receptor Inhibitors for the Control of Breast Cancer
Q42381796Comparison of the Effects of Glutamine, Curcumin, and Nesfatin-1 on the Gastric Serosal Surface Neomucosa Formation: An Experimental Rodent Model.
Q50052813Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment
Q98293097Dual Targeting of VEGFR2 and C-Met Kinases via the Design and Synthesis of Substituted 3-(Triazolo-thiadiazin-3-yl)indolin-2-one Derivatives as Angiogenesis Inhibitors
Q64069690Harmine suppresses bladder tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis
Q47614531Medicinal Attributes of Thienopyrimidine Based Scaffold Targeting Tyrosine Kinases and Their Potential Anticancer Activities.
Q37701501Novel multiple tyrosine kinase inhibitor ponatinib inhibits bFGF-activated signaling in neuroblastoma cells and suppresses neuroblastoma growth in vivo
Q90577575Regulation of Protein Activity and Cellular Functions Mediated by Molecularly Evolved Nucleic Acids
Q92419217Synthesis and biological evaluation of novel (E)-N'-benzylidene hydrazides as novel c-Met inhibitors through fragment based virtual screening
Q54987450Targeting MET in cancer therapy.
Q64253749Targeting Tyrosine kinases in Renal Cell Carcinoma: "New Bullets against Old Guys"
Q39274990The c-Met receptor: Implication for targeted therapies in colorectal cancer
Q38711866miR-205 mediates the inhibition of cervical cancer cell proliferation using olmesartan

Search more.